Register für Schwere Immunzytopenien - Severe Immune Cytopenia Registry (SIC-Reg.Org)

Status: Completed
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Prospective registry study for children and young adults with severe immune cytopenias (persisting/chronic immune thrombocytopenia, autoimmune hemolytic anemia, and Evans syndrome) to improve the management, facilitate the differential diagnostic work-up, and document the clinical course under various treatments. Time points: at inclusion, after 6 months, after 12 months, then yearly up to 4 years after inclusion. No intervention, mere observation and documentation. Guided pre-inclusion (differential) diagnostic work-up.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Maximum Age: 25
Healthy Volunteers: f
View:

• Autoimmune hemolytic anemia (AIHA)

• Evans syndrome (ES)

• Persistent or chronic immune thrombocytopenia (ITP; \>6 months after first manifestation)

Locations
Other Locations
Austria
Pediatric Hematology-Oncology Outpatient Clinic
Graz
Time Frame
Start Date: 2018-03-09
Completion Date: 2024-12-31
Participants
Target number of participants: 80
Treatments
patients
all who fulfil inclusion criteria and consent to participation; potential biomarkers will be documented
Sponsors
Leads: Medical University of Graz

This content was sourced from clinicaltrials.gov

Similar Clinical Trials